Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
aspirin alone
DRUG
2 trials
Sponsors
UMC Utrecht
, sohag university
Conditions
Arteriosclerosis
Brain Ischemia
Eye Diseases Genetic Diseases Injury, Occupational Diseases, Poisoning Mental and Behavioural Disorders defective vision
Transient Ischemic Attack
Phase 4
ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
Completed
NCT00161070
UMC Utrecht
Arteriosclerosis, Brain Ischemia, Transient Ischemic Attack
Start: 1997-07-31
End: 2006-12-31
Target: 4500
Updated: 2007-03-22
Unknown Phase
Comparitive study of Argon Laser and Aspirin in treatment of central serous chorioretinopathy
Active, not recruiting
PACTR201706002163811
sohag university
Eye Diseases Genetic Diseases Injury, Occupational Diseases, Poisoning Mental and Behavioural Disorders defective vision
Start: 2014-01-07
Target: 60
Updated: 2026-09-14
Related Papers
The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients.
2011-02-17
81 citations
Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
2007-02-01
130 citations
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
2006-05-01
563 citations